- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05090553
Protocol for an Analytical Study With Microbiological, Phenotypic, Genotypic and Multiomics Techniques
Cutibacterium Acnes Colonization on Intervertebral Discs of Patients With Low Back Pain: Protocol for an Analytical Study With Microbiological, Phenotypic, Genotypic and Multiomics Techniques
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Vinicius M da Rocha, MD
- Phone Number: 55 21 99700-7240
- Email: viniciusmagnodarocha@gmail.com
Study Locations
-
-
-
Rio de Janeiro, Brazil, 20270-004
- Recruiting
- Hospital Universitario Gaffree e Guinle
-
Contact:
- Vinicius M da Rocha, MD
- Phone Number: 55 21 99700-7240
- Email: viniciusmagnodarocha@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- low back pain lasting longer than 3 months;
- MRI findings of degenerative lumbar discopathy (DDL) performed less than 6 months after inclusion in the study;
- indication for open surgical treatment, with isolated microdiscectomy or associated with lumbar arthrodesis;
- failure of conservative treatment for at least 6 weeks and/or progressive neurological deficit
Exclusion Criteria:
- History of open lumbar spine surgery at any stage of life;
- presence of chemotherapy or pulse therapy with corticoids;
- patients with immune deficiency;
- patients undergoing previous intradiscal therapies (nucleotomy or discography);
- patients undergoing previous endoscopic surgery;
- patients with a history of previous spinal infection treated with antibiotics in the 6 months prior to inclusion in the study;
- use of antibiotics in the 2 months prior to the surgical procedure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: surgical treatment
Lumbar Spinal Fusion Surgery
|
During surgery will be collected five disc fragments and five fragments of muscle-ligament tissue adjacent to the collected disc.
|
Experimental: Bacterial culture
Cutibacterium acnes culture in two different atmosphere:
|
Samples will be seeded on blood agar and anaerobic blood agar plates.
After sowing in solid media, the swab will be inoculated in thioglycolate medium, where it will remain for 14 days
|
Experimental: Phenotypic and genotypic characterization
Mass spectrometry and (Polimerase Chain Reaction) PCR
|
The phenotypic identification of the species will be carried out through mass spectrometry, with the MALDI-TOF equipment. PCR analyzes performed in two phases, the first to confirm the presence of bacteria (target and non-target) using primers capable of amplifying eubacteria ribosomal deoxyribonucleic acid (rDNA) 16s and the second directed to confirm C. acnes through specific rDNA 16s primers. |
Experimental: Multiomics analysis
|
Whole Genome Sequencing, proteomics and metabolomics analysis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of C. acnes on intervertebral disc
Time Frame: Up to 5 months
|
Incidence of C. acnes on intervertebral disc in patients with chronic low back pain and DDL.
|
Up to 5 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VMRDocProtocol_2021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Disc Disease
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
Assiut UniversityNot yet recruiting
-
Spine BioPharma, IncMCRARecruitingLumbar Degenerative Disc DiseaseUnited States
-
AxioMed Spine CorporationUnknownDegenerative Disc Disease (DDD)United States, Germany
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom
-
Synergy Spine SolutionsMCRARecruitingCervical Degenerative Disc DiseaseUnited States
-
Orthofix Inc.TerminatedCervical Degenerative Disc DiseaseUnited States
-
Yuhan CorporationCompletedDisc Degenerative DiseaseKorea, Republic of
-
Synergy Spine SolutionsMCRANot yet recruitingCervical Degenerative Disc DiseaseUnited Kingdom
Clinical Trials on Lumbar Spinal Fusion Surgery
-
Olympus Biotech CorporationCompleted
-
Rigshospitalet, DenmarkFrederiksberg University HospitalCompleted
-
Bergman ClinicsMICN Lab, University Hospital ZurichCompletedLow Back Pain | Disk Herniated Lumbar | Spinal Stenosis LumbarFrance, Austria, Netherlands
-
K2M, Inc.Recruiting
-
Mesoblast, Ltd.CompletedDegenerative Disc Disease | Spinal Stenosis | Degenerative SpondylolisthesisUnited States
-
St. Olavs HospitalKarolinska InstitutetCompletedIntermittent Claudication | Spinal Stenosis
-
Gansu Provincial HospitalActive, not recruiting
-
Seoul National University HospitalCompleted
-
University Hospital AugsburgBoston Scientific CorporationRecruitingLow Back Pain | Spinal Fusion | Neuromodulation | Failed Back Surgery Syndrome | Spinal Cord Stimulation | SCSGermany
-
Seoul National University HospitalCompleted